Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-06

Clinical Trial Update: Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) [Phase 2, Phase 3]

View source ↗

Summary

The document reports that the Emergency NGO Onlus–sponsored EASE trial evaluating amiodarone for Ebola Virus Disease in Sierra Leone has been withdrawn (Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)

Snippet

Sponsor: Emergency NGO Onlus | Conditions: Ebola Virus Disease | Phase 2, Phase 3 | Status: WITHDRAWN